Owing to the importance of MAPK signalling molecules i.e. ERK, JNK and p38, in the activation, proliferation, migration and degranulation of immune cells involved in AD, therefore pharmacological inhibition of this pathway may serve as an attractive strategy for the treatment of allergic disorders (Huang et al., 2019). This evidence concerns the gene MAPK8 and Alzheimer disease.